Tech Company Financing Transactions
Craif Funding Round
Aozora Bank participated in a $22 million Series C funding round for Craif. This venture round was announced on 4/27/2025.
Transaction Overview
Company Name
Announced On
4/27/2025
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$22,000,000
Round
Series C
Investors
Proceeds Purpose
Craif aims to address these gaps by providing a noninvasive urine-based test that enables early cancer detection, even at a very early stage.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
5F Hongo ITP Office, 2-25-7 Yushima, Bunkyo-ku
Tokyo, 113-0034
JP
Tokyo, 113-0034
JP
Phone
Website
Email Address
Overview
WE ENSURE LIFELONG HEALTH FOR EVERYONE; Our mission is to detect cancer in the earliest stages using urine. Our core technology is the unique nanowire device capable of extracting 99% of exosomes, known for their deep relationship with diseases, making them promising biomarkers. We will provide accurate and unpainful early cancer detection method to create a society where everyone can stay healthy throughout their lifetime.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ryuichi Onose
Browse more venture capital transactions:
Prev: 4/26/2025: EyeMD EMR Healthcare Systems venture capital transaction
Next: 4/27/2025: ARX Robotics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs